Literature DB >> 22740900

Serum levels of cystatin C in elderly lung cancer patients.

Gen Ohara1, Kunihiko Miyazaki, Koichi Kurishima, Katsunori Kagohashi, Hiroichi Ishikawa, Hiroaki Satoh, Nobuyuki Hizawa.   

Abstract

The purpose of this study was to confirm the correlation between serum levels of cystatin C (Cys-C) and those of creatinine (Cre), the most widely used index of renal function in clinical practice, and to evaluate serum levels of Cys-C, with a particular focus on the effects of aging, body mass index (BMI), C-reactive protein (CRP) and disease extent in patients with lung cancer. Serum Cys-C levels in a total of 39 patients (median 72 years), who were diagnosed as having lung cancer were analyzed retrospectively. The serum Cys-C was determined using colloidal gold particles coated with anti-Cys C antibodies. A significant correlation coefficient was found between serum levels of Cys-C and those of Cre (P=0.001), but only moderate agreement. Serum Cys-C levels increased in an age-dependent manner with significant differences among 3 age groups: patients younger than 65 years, those aged 65 to 74 years and those aged 75 years or older (P=0.001). However, no correlation was observed between Cys-C and BMI, Cys-C and CRP, or Cys-C and disease extent of lung cancer. Estimation of renal function is important since renal insufficiency is directly correlated to increased chemotherapeutic complications in oncological practice. Thus, estimation of serum Cys-C levels may be important, but adjustment of Cys-C for age should be taken into consideration.

Entities:  

Year:  2011        PMID: 22740900      PMCID: PMC3362379          DOI: 10.3892/ol.2011.377

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

Authors:  D Fliser; E Ritz
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

Review 2.  Diagnostic applications of cystatin C.

Authors:  C H Reed
Journal:  Br J Biomed Sci       Date:  2000       Impact factor: 3.829

3.  Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy.

Authors:  B Stabuc; L Vrhovec; M Stabuc-Silih; T E Cizej
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

4.  Cystatin C: a marker of renal function or something more?

Authors:  Gary Curhan
Journal:  Clin Chem       Date:  2005-02       Impact factor: 8.327

5.  Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.

Authors:  David Singh; Mary A Whooley; Joachim H Ix; Sadia Ali; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2007-01-08       Impact factor: 5.992

6.  Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer.

Authors:  Lubomir Bodnar; Gabriel Benedykt Wcislo; Marta Smoter; Agnieszka Gasowska-Bodnar; Rafał Stec; Agnieszka Synowiec; Cezary Szczylik
Journal:  Kidney Blood Press Res       Date:  2010-08-17       Impact factor: 2.687

7.  Lung cancer in patients aged 80 years and over.

Authors:  Hiroaki Satoh; Koichi Kurishima; Ryota Nakamura; Hiroichi Ishikawa; Katsunori Kagohashi; Gen Ohara; Shigemi Ishikawa; Morio Ohtsuka; Kiyohisa Sekizawa; Nobuyuki Hizawa
Journal:  Lung Cancer       Date:  2008-12-02       Impact factor: 5.705

8.  Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.

Authors:  Nele J Van Den Noortgate; Wim H Janssens; Joris R Delanghe; Marcel B Afschrift; Norbert H Lameire
Journal:  J Am Geriatr Soc       Date:  2002-07       Impact factor: 5.562

9.  Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate.

Authors:  A Grubb; O Simonsen; G Sturfelt; L Truedsson; H Thysell
Journal:  Acta Med Scand       Date:  1985

10.  Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.

Authors:  Anders Grubb; Jonas Björk; Ulf Nyman; Joanna Pollak; Johan Bengzon; Gustav Ostner; Veronica Lindström
Journal:  Scand J Clin Lab Invest       Date:  2011-01-04       Impact factor: 1.713

View more
  6 in total

1.  Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia.

Authors:  Feilong Yang; Dawei Li; Yu Di; Yongzhen Zhang; Yuanwei Zang; Juchao Ren; Lei Yan; Zunlin Zhou; Hainan Liu; Zhonghua Xu
Journal:  Biomed Res Int       Date:  2017-07-24       Impact factor: 3.411

2.  Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors.

Authors:  Hui Wang; Lijian Gao; Cuiyu Meng; Nengwang Yu; Feilong Yang; Cong Zhang; Dawei Li; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Biomed Res Int       Date:  2018-01-29       Impact factor: 3.411

3.  Salivary Proteome Profile of Women during Fertile Phase of Menstrual Cycle as Characterized by Mass Spectrometry.

Authors:  Ganesan Saibaba; Durairaj Rajesh; Subramanian Muthukumar; Ganesan Sathiyanarayanan; Archunan Priya Aarthy; Govindaraju Archunan
Journal:  Gynecol Minim Invasive Ther       Date:  2021-11-05

4.  Detection of cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits.

Authors:  Renren Jiang; Chao Xu; Xiaoli Zhou; Tianhao Wang; Gang Yao
Journal:  J Transl Med       Date:  2014-09-12       Impact factor: 5.531

5.  Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma.

Authors:  Nada E Hammouda; Manal A Salah El-Din; Mamdouh M El-Shishtawy; Amal M El-Gayar
Journal:  Sci Pharm       Date:  2017-03-08

6.  Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden.

Authors:  Woo Sun Kwon; Tae Soo Kim; Chung Hyun Nahm; Yeonsook Moon; Jin Ju Kim
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.